SF3B1 rs559063155: Understanding the K700E Mutation
The rs559063155 variant in the SF3B1 gene represents a specific genetic change known as K700E. This mutation is frequently identified in patients with certain hematologic malignancies, such as myelodysplastic syndromes, where it influences how cells process genetic information.
What each genotype means
Typical SF3B1 profile
This genotype represents the common, non-mutated sequence for this position in the SF3B1 gene. It is the standard form found in the vast majority of the healthy population.
This is the most common genotype found in the general population.
Somatic mutation carrier
This genotype corresponds to the K700E mutation, a recurrent somatic change often identified in patients with myelodysplastic syndromes. Because this is typically a somatic mutation acquired during a person's lifetime rather than an inherited one, you should discuss any clinical findings or blood test results with a hematologist or oncologist.
This variant is extremely rare in healthy populations and is primarily identified in cohorts with hematologic malignancies.
Somatic mutation carrier
This genotype represents a non-canonical substitution at this locus, which is categorized as potentially pathogenic in clinical databases. As this variant is associated with hematologic conditions like acute myeloid leukemia, please consult with a medical professional to interpret these results in the context of your overall health.
This specific genotype is very rare in the general population and is typically observed in clinical oncology settings.
Somatic mutation carrier
This genotype represents a non-canonical substitution at this locus, which is categorized as potentially pathogenic in clinical databases. Because this variant is linked to hematologic malignancies, it is important to discuss these findings with a qualified clinician to understand their clinical relevance.
This specific genotype is very rare in the general population and is typically observed in clinical oncology settings.
What is the rs559063155 Variant?
The variant rs559063155, commonly referred to as K700E, is a missense mutation located within the SF3B1 gene. In genetics, a missense mutation occurs when a single nucleotide change results in the substitution of one amino acid for another in the final protein product. Specifically, this mutation replaces the amino acid lysine (K) with glutamic acid (E) at position 700 of the SF3B1 protein. This specific site is highly conserved, meaning it has remained largely unchanged throughout evolutionary history, which often suggests that the protein's function at this location is critical. Because this variant is typically found as a somatic mutation—meaning it is acquired in specific cells during a person's lifetime rather than being inherited from parents—it is most often studied in the context of cancer research and hematology rather than as a hereditary trait.
The Role of the SF3B1 Gene
The SF3B1 gene provides instructions for creating a protein that is a vital component of the spliceosome. The spliceosome is a complex molecular machine within the cell nucleus responsible for pre-mRNA splicing, a process that removes non-coding segments called introns from genetic transcripts and joins the coding segments, known as exons, together. By ensuring that exons are correctly identified and linked, SF3B1 helps the cell produce functional proteins. When SF3B1 is mutated, such as in the case of K700E, the spliceosome's ability to recognize the correct 'branch points' or splice sites can be disrupted. This can lead to the activation of cryptic or hidden splice sites, resulting in the production of altered mRNA transcripts. These errors can ultimately affect the expression levels of various genes and the stability of the proteins they encode, contributing to the cellular dysfunction observed in certain disease states.
Research and Clinical Associations
Research has strongly associated the SF3B1 K700E mutation with myelodysplastic syndromes (MDS) and other hematologic malignancies, including chronic lymphocytic leukemia. Studies indicate that this mutation disrupts the interaction between SF3B1 and other splicing factors, such as SUGP1, which leads to widespread changes in how the cell recognizes splice sites. Interestingly, while many cancer-associated mutations are linked to poor outcomes, some clinical research has observed that patients with MDS who carry the specific K700E mutation may experience a more favorable prognosis compared to those with other types of SF3B1 mutations or those without the mutation. However, the evidence regarding clinical outcomes can be mixed, and the biological consequences—such as increased nonsense-mediated decay of mRNA—are complex. Because this is a specialized area of oncology, the clinical significance of this variant is primarily used by hematologists to help characterize the molecular profile of a patient's condition.
Population Frequency
The rs559063155 variant is extremely rare in the general, healthy population. It is not considered a common polymorphism that one would typically find in standard genetic screening panels for ancestry or general health traits. Instead, its presence is significant primarily within cohorts of individuals diagnosed with specific hematologic malignancies. Because it is a somatic mutation, it is not typically passed down through generations, and its frequency is measured by its prevalence in tumor samples rather than in the germline of the general public.
What This Information Means for You
If you have encountered this variant in a clinical report, it is essential to understand that this information is highly technical and specific to the context of a medical diagnosis. This variant is not a predictive marker for general health in the absence of a diagnosed condition. If you or a family member are dealing with a hematologic condition, this genetic information should be discussed directly with a hematologist or an oncologist. These professionals can interpret the presence of the K700E mutation in the context of your specific clinical history, blood work, and other diagnostic tests. You should never use information about this variant to make decisions about your health or treatment without direct guidance from your medical team. They are the only ones who can provide an accurate assessment of what this finding means for your specific health situation and potential care plan.
How common is this variant?
The rs559063155 variant is extremely rare in healthy populations and is primarily identified in cohorts of patients with hematologic malignancies.
Frequently asked questions
Is the SF3B1 K700E mutation inherited?
No, the K700E mutation is typically a somatic mutation. This means it is acquired in specific cells during a person's lifetime and is not passed down from parents to children.
What does SF3B1 do in the body?
SF3B1 is a protein that helps the cell perform pre-mRNA splicing. It ensures that genetic instructions are correctly assembled so that the cell can produce the proteins it needs to function.
Does having this mutation mean I have cancer?
The presence of this mutation is often associated with certain blood disorders and cancers, but it is not a standalone diagnostic test. Only a qualified physician can interpret genetic findings in the context of a full clinical evaluation.
Can I change my SF3B1 genotype?
No, genetic variants are not something that can be changed through lifestyle or diet. If this mutation is present in your cells, it is a biological feature of those specific cells that requires medical management.
Sources & further reading
Educational information only, last refreshed 9/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs559063155?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29